Tscan Therapeutics (TCRX) Q4 2024 Earnings

Nov 12Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.32
-0.28
-0.25
-0.21

Details

Expected EPS
-0.315362
Actual EPS
-0.25
Surprise EPS
0.07
Surprise Percent
+20.73%

Description

⁨Tscan Therapeutics⁩ (⁦TCRX⁩) has reported earnings of ⁦-0.25⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts